Patient info Open main menu

Alverine Citrate 60 mg hard capsules – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Pharmacy medicine (P) Details

Medicine strength:
60 mg
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Alverine Citrate 60 mg hard capsules

1. What Alverine Citrate Capsules are and what they are used for

Alverine Citrate Capsules are an “anti-spasmodic” medicine. It relaxes the muscles in the intestine (gut) and uterus (womb). This helps stop the pain you feel when the muscles become tense.

It is used to help people who have Irritable Bowel Syndrome (IBS), some of the symptoms of IBS are:

  • Abdominal pains like cramp which come and go. • Diarrhoea.
  • Constipation.
  • Feeling full and bloated.
  • Wanting to go to the toilet urgently.

Sometime these symptoms are worse if you are worried or under stress.

Alverine Citrate Capsules can also be used for a condition of the large intestine called painful diverticular disease of the colon and to relieve period pains.

2. What you need to know before you take Alverine Citrate Capsules

Do not take Alverine Citrate Capsules if:

  • you are allergic to alverine citrate or any of the other ingredients of this medicine (listed in section 6).
  • your doctor has told you that you have obstruction of the gut or that your small bowel is not working properly.

Warnings and precautions

If this is the first time you have had these symptoms, consult your doctor before using any treatment.

Do not take Alverine Citrate Capsules if any of the following apply to you, it may not be the right treatment for you.

See your doctor as soon as possible if you:

  • are aged 40 years or over,
  • have passed blood from the bowel,
  • are feeling sick or vomiting,
  • have lost your appetite or lost weight,
  • are looking pale and feeling tired,
  • are suffering from severe constipation, • have a fever,
  • have recently travelled abroad,
  • are, or may be, pregnant,
  • are breast-feeding,
  • have abnormal vaginal bleeding or discharge, • have difficultly or pain in passing urine.

Consult your doctor if you have developed new symptoms, or if your symptoms worsen, or if they do not improve after 2 weeks treatment.

Children

Alverine Citrate Capsules are not suitable for children under 12 years old.

Other medicines and Alverine Citrate Capsules

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Some medicines can affect the way other medicines work.

Alverine Citrate Capsules with food and drink

Alverine Citrate Capsules may be taken with or without food.

Pregnancy and breast-feeding

Do not take Alverine Citrate Capsules during pregnancy or whilst breast-feeding.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

You should be aware of how you react to Alverine Citrate Capsules before you drive or operate machinery. If you feel dizzy or drowsy after taking Alverine Citrate Capsules, do not drive or operate machinery until these effects wear off.

3. How to take Alverine Citrate Capsules

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • The recommended dose is 1 or 2 capsules of 60mg or 1 capsule of 120mg taken up to 3 times a day.

Use in children: Alverine Citrate Capsules are not suitable for children under 12 years old.

If you take more Alverine Citrate Capsules than you should

If you take more Alverine Citrate Capsules than you should, contact a doctor immediately. Symptoms of an overdose may be low blood pressure, dizziness, increased heartbeat, dilated pupils, blurred vision, dry mouth and throat, difficulty breathing, or difficulty passing urine.

If you forget to take Alverine Citrate Capsules

If you forget to take Alverine Citrate Capsules, take it when you remember. If you forget for more than 4 hours, just take the next dose when you remember it is due.

Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Alverine Citrate Capsules and seek urgent medical advice immediately if you notice:

  • Difficulties in breathing, shortness of breath, wheezing, swelling of your face or other parts of your body, as serious allergic reactions have been known to occur.
  • Yellowing of the whites of the eyes or skin, as inflammation of the liver has been known to occur.

Tell your doctor or pharmacist if any of the following side effects occur or worsen.

The following other side effects may also occur:

Not known (frequency cannot be estimated from the available data):

  • a feeling of sickness or dizziness,
  • headache,
  • allergic reactions, which may include itching or skin rash,
  • increased levels of some liver enzymes (which would be detected by your doctor during a blood test). Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine. PACKAGE LEAFLET: INFORMATION FOR THE USER

Alverine Citrate 60mg and 120mg Hard Capsules

5. How to store Alverine Citrate Capsules

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the blister and carton after ‘EXP’. The expiry date refers to the last day of that month.

Do not store above 30oC.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Alverine Citrate Capsules contain

  • The active substance is alverine citrate. Each hard capsule contains either 60mg or 120mg of alverine citrate.
  • The other ingredients are maize starch; starch, pregelatinised and magnesium stearate.
  • The capsule shell contains gelatin, titanium dioxide (E 171), indigo carmine (E 132) and iron oxide black (E 172). Printing ink components are shellac (E 904), propylene glycol (E 1520), black iron oxide (E 172) and potassium hydroxide (E 525).

What Alverine Citrate Capsules look like and contents of the pack

Alverine Citrate 60mg Hard Capsules are hard gelatin capsules, size 3 with opaque blue colour body and opaque grey colour cap marked ‘I 64’ containing white to off-white powder.

Alverine Citrate 120mg Hard Capsules are hard gelatin capsules, size 1 with opaque blue colour body and opaque grey colour cap marked ‘I 65’ containing white to off-white powder.

Pack size of 7, 10, 14, 28, 30, 56, 60, 84, 90, 100 and 112 capsules are available.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Morningside Healthcare Ltd.

Unit C, Harcourt Way

Leicester, LE19 1WP, UK

Manufacturer

Morningside Pharmaceuticals Ltd.

5 Pavilion Way

Loughborough, LE11 5GW, UK

Morningside Pharmaceuticals Ltd. & Aspire Pharma Ltd. Second Floor, Boss Court, 7 Barton Close, Grove Park, Leicester, LE19 1SJ, United Kingdom

Aspire Pharma Ltd.

Unit 4, Rotherbrook Court,

Bedford Road, Petersfield,

GU32 3QG, United Kingdom.

Health tips for you

Try to make your everyday life a bit healthier:

  • Allow plenty of time to do things, and avoid stress. • Do not rush meals.
  • Try to eat a balanced diet with high fibre foods. • Do not eat foods which seem to make your IBS worse.

This leaflet was last revised in March 2025.

MPL16416

MPL16423 - P1.1

Size: 60 & 100 capsules

PL/PA no: PL 20117/0289-0290

Type: Leaflet

Reason for request: Type IAin bulk submission

Version no: 1.1

Date of revision: 31.03.25

Colours: As swatches

Font(s): Nimbus Sans L

A/W software: Indesign CC

For submission only

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20117/0289

Last revision stated in the text: 31 March 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Alverine Citrate 60 mg hard capsules

Prescription needed? No, but it is sold only in pharmacies (P)
Active substance Alverine
Strength 60 mg
Pharmaceutical form Oral capsule
Hard gelatin capsules, size 3 with opaque blue colour body and opaque grey colour cap marked ‘I 64’ containing white to off-white powder.
How is it taken Oral
Excipients Maize starch,, Starch, pregelatinised,, Magnesium stearate., Indigo carmine (E 132),, Titanium dioxide (E 171),, Gelatin., Iron oxide black (E 172),, Shellac (E 904),, Propylene glycol (E 1520),, Black iron oxide (E 172),, Potassium hydroxide (E 525).
Pack sizes 100 capsule
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
Storage Do not store above 30°C.
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A03 Drugs for functional gastrointestinal disorders
      1. A03A Drugs for functional gastrointestinal disorders
        1. A03AX Other drugs for functional gastrointestinal disorders
          1. A03AX08 alverine
Marketing authorisation PL 20117/0289 (first authorised 7 June 2017)
Marketing authorisation holder Morningside Healthcare Ltd
Codes GTIN 5055132716416 · BNF 01020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.